Description
Retatrutide (GLP3) Reta
Retatrutide research peptide from Frontier Peptide Labs is supplied as a lyophilized (freeze-dried) powder in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, and 50mg vial formats, intended strictly for laboratory research use. Each batch is manufactured to exceed 99% purity and verified by HPLC and LC-MS testing through an ISO 17025-accredited laboratory.
Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide studied in preclinical models as a triple agonist of the GIP, GLP-1, and glucagon receptors.
Mechanism of Action
Studied as a single molecule engaging three receptors — GIPR, GLP-1R, and the glucagon receptor (GCGR) — with the glucagon arm distinguishing it mechanistically from dual incretin agonists.
Vial Format
Supplied lyophilized in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, and 50mg strengths. Requires reconstitution in bacteriostatic or sterile water before laboratory use.
Research Resources
Browse the Research Library and Research Guides.
About the Retatrutide Research Peptide
Retatrutide is built on the GIP peptide backbone and carries a C20 fatty diacid moiety that promotes albumin binding and extends circulating half-life. Unlike tirzepatide, which engages two receptors, retatrutide was engineered for agonism at three: GIPR, GLP-1R, and GCGR. Relative potency differs across the three receptors rather than being balanced; the reported values are given in the primary literature. In diet-induced obese rodent models described by Coskun and colleagues (Cell Metabolism, 2022), chronic administration produced dose-dependent reductions in food intake and body weight. The glucagon receptor component is associated in that work with increased energy expenditure, a contribution not available to dual GIP/GLP-1 agonists. Published phase 2 clinical literature in humans also exists; Frontier Peptide Labs supplies this material solely as a laboratory research reagent and makes no claim regarding human outcomes.
Quality & Testing
Every Retatrutide batch is manufactured to exceed 99% purity and tested using HPLC and LC-MS protocols through an ISO 17025-accredited laboratory, confirming identity, potency, and batch-to-batch consistency. A batch-specific Certificate of Analysis is available on request — see Reading a Certificate of Analysis for how to interpret the chromatograms.
Handling & Storage
- Store cold and away from light on arrival
- Short-term (days–weeks): refrigerate at 4°C
- Long-term (months+): freeze at −20°C to −80°C
- Full detail: Cold-Chain Receiving and Storage for Research Peptides
- Reconstitution math: Retatrutide reconstitution calculator and Bacteriostatic Water vs. Sterile Water
Related Research Products & Resources
Retatrutide Research FAQs
What is Retatrutide?
Retatrutide (LY3437943) is a synthetic 39-amino-acid peptide studied in preclinical research as a triple agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR).
Why is Retatrutide sometimes called GLP-3?
GLP-3 is an informal supplier and research-community shorthand referring to retatrutide as the third-generation successor to GLP-1 and dual GIP/GLP-1 agonists. It is not a formal receptor name or an official designation, and it carries no human-use meaning.
How does Retatrutide differ from Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist. Retatrutide adds a third target, the glucagon receptor, for triple-receptor agonism. See the Retatrutide vs. Tirzepatide comparison for the full mechanistic breakdown.
What vial strengths are available for Retatrutide?
This product is supplied in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, and 50mg lyophilized vials.
How is Retatrutide purity verified?
Each batch is manufactured to exceed 99% purity and tested by HPLC and LC-MS through an ISO 17025-accredited laboratory. HPLC evaluates the separation profile and purity; LC-MS confirms molecular identity. A batch-specific COA is available on request.
Is Frontier Peptide Labs Retatrutide for research use only?
Yes. It is intended exclusively for laboratory research and development purposes. It is not for human consumption, veterinary use, diagnostic use, cosmetic use, therapeutic application, or medical treatment.
Research Use Only: This product is intended exclusively for laboratory research and development. It is not for human consumption, veterinary use, diagnostic use, cosmetic use, therapeutic application, or medical treatment. Purchasers are responsible for compliance with all applicable federal, state, and local regulations.

Reviews
There are no reviews yet.